Approval · Notice of Compliance 23485 · 2020
CUVPOSA: Notice of Compliance 23485
Issued April 20, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 23485
- Date
- April 20, 2020
- Company
- Medexus Pharmaceuticals Inc.Bolton, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Merger - buyout
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CUVPOSA | 02469332 | Marketed |
Medicinal ingredients
- GLYCOPYRROLATE 1 MG per 5ML